DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc.
Stage unknownSouth San Francisco, CABiotechnology
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 1
Financing history
1 rounds
- Jul 9, 2024Form D equity offering · $325M (form d sold) · 26 investorsFact SEC EDGAR Form D data sets (quarterly) · “Arsenal Biosciences, Inc. filed Form D: $325,352,578 sold of $325,352,578, Biotechnology”
Investors on record
1 edges
- Westlake Biopartners, LLC board only, Beth Seidenberg (strongly supported) Inference sec.gov
People
3 officers, 5 directors
- Irene Pleasure Executive Officer sec.gov
- James Ahlers Executive Officer sec.gov
- Kenneth Drazan Executive Officer/Director sec.gov
- Matthew Fust Director Fact
- Valentin Barsan Director Fact
- Sean Parker Director Fact
- Brook Byers Director Fact
- Beth Seidenberg Director Inference
Timeline
1
- Sep 4, 2024Arsenal Biosciences, Inc. filed Form D: $325,352,578 sold of $325,352,578, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
14 observations
Every observation on this company
- Entity type: Corporation Sep 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Sep 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Sep 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Sep 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Sep 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Sep 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $325M Sep 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $325M Sep 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Sep 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2024-07-09 Sep 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 26 Sep 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Sep 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity Sep 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 329 Oyster Point Blvd, South San Francisco, CA, 94080 Sep 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)